Antiproliferative Evaluation of Isofuranodiene on Breast and Prostate Cancer Cell Lines
Figure 3
Cell viability in MDA-MB 231, BT 474, and PC 3 cell lines. (a) Percentage of cell viability after treatment with isofuranodiene at doses of 10–150 M after 72 h of incubation. (b), (c), and (d) Percentage of cell viability after treatment with isofuranodiene at doses of 10–150 M at different incubation times (2, 6, 12, 24, 48, and 72 h). The results are reported as (viability of treated cells)/(viability of control cells) × 100 and represent the average of three independent experiments with a maximum SD lower than ±8.0.
